|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Kidney Cancer | |||||
| Von Hippel-Lindau Syndrome | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Carcinoma, Renal Cell | |||||
| Kidney Neoplasms | |||||
| Syndrome | |||||
| Von Hippel-Lindau Disease | |||||
| 3 | More general conditions related to this trial | ||||
| Adenocarcinoma | |||||
| Angiomatosis | |||||
| Carcinoma | |||||
| Cardiovascular Diseases | |||||
| Disease | |||||
| Kidney Diseases | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| Neoplasms by Site | |||||
| Neoplasms, Glandular and Epithelial | |||||
| Nervous System Diseases | |||||
| Neurocutaneous Syndromes | |||||
| Pathologic Processes | |||||
| Urogenital Neoplasms | |||||
| Urologic Diseases | |||||
| Urologic Neoplasms | |||||
| Vascular Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| mutation analysis | |||||
| 5 | Sponsors listed in this trial | ||||
| NCI - Center for Cancer Research-Medical Oncology | |||||
| National Cancer Institute (NCI) | |||||